
Acrux Ltd
ASX:ACR

Operating Margin
Acrux Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
AU |
![]() |
Acrux Ltd
ASX:ACR
|
6.1m AUD |
-156%
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
660.9B USD |
42%
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
3%
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
424.9B USD |
26%
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
203.1B CHF |
33%
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
182B GBP |
24%
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
1.5T DKK |
46%
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
194.2B CHF |
33%
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
211.9B USD |
38%
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
183.4B USD |
11%
|
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
143B USD |
29%
|
Acrux Ltd
Glance View
Acrux Ltd. operates as a pooled development fund that invests in pharmaceutical businesses. The company is headquartered in Melbourne, Victoria. The company went IPO on 2004-09-29. The firm is engaged in developing and commercializing a portfolio of generic topical prescription pharmaceutical products which use dermal and transdermal drug delivery technology. The firm's product pipeline includes Evamist, Lenzetto, Jublia, EMLA and Testosterone Topical Solution. The firm's transdermal or topical pharmaceutical product portfolio can be segregated into approximately two streams, such as generic pharmaceutical products and specialty pharmaceutical products. The products offered by the Company are the testosterone topical solution to treat adult males who have low or no testosterone and Estradiol MDTS to treat moderate to severe hot flushes commonly associated with menopause. The company is also developing a range of topical and dermatological generic products for the United States market. The firm operates in the United States, Europe and other markets.

See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Acrux Ltd's most recent financial statements, the company has Operating Margin of -156%.